The Efficacy of Probiotics As Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature

Overview

Journal Microorganisms

Specialty Microbiology

Date 2022 Dec 23

PMID 36557645

Authors

Andrej Steyer

Dusanka Micetic-Turk

Sabina Fijan

Affiliations

Soon will be listed here.

Abstract

Enteric viruses, including the rotavirus, norovirus, and adenoviruses, are the most common cause of acute gastroenteritis. The rotavirus disease is especially prevalent among children, and studies over the past decade have revealed complex interactions between rotaviruses and the gut microbiota. One way to treat and prevent dysbiosis is the use of probiotics as an antiviral agent. This review focuses on the latest scientific evidence on the antiviral properties of probiotics against rotavirus gastroenteric infections in children. A total of 19 studies exhibited a statistically significant antiviral effect of probiotics. The main probiotics that were effective were var. GG, and various multi-strain probiotics. The underlying mechanism of the probiotics against rotavirus gastroenteric infections in children included immune enhancement and modulation of intestinal microbiota leading to shortening of diarrhoea. However, several clinical studies also found no significant difference in the probiotic group compared to the placebo group even though well-known strains were used, thus showing the importance of correct dosage, duration of treatment, quality of probiotics and the possible influence of other factors, such as the production process of probiotics and the influence of immunisation on the effect of probiotics. Therefore, more robust, well-designed clinical studies addressing all factors are warranted.

Citing Articles

Viral diarrheas - newer advances in diagnosis and management.

Acevedo-Rodriguez J, Contreras C, Ochoa T Curr Opin Infect Dis. 2024; 37(5):385-391.

PMID: 39253867 PMC: 11669399. DOI: 10.1097/QCO.0000000000001053.

Acute Infectious Diarrhea.

Poeta M, Del Bene M, Lo Vecchio A, Guarino A Adv Exp Med Biol. 2024; 1449:143-156.

PMID: 39060736 DOI: 10.1007/978-3-031-58572-2_9.

Postbiotic Activities of : Impacts on Viability, Structural Integrity, and Cell Death Markers in Human Intestinal C2BBe1 Cells.

Hernandez M, Sieger M, Barreto A, Guerrero C, Ulloa J Pathogens. 2024; 13(1).

PMID: 38251325 PMC: 10818886. DOI: 10.3390/pathogens13010017.

Acute gastroenteritis-changes to the recommended original oral rehydrating salts: a review.

Lifschitz C, Kozhevnikov O, Oesterling C, Anbar A, Walker S Front Pediatr. 2024; 11:1294490.

PMID: 38192370 PMC: 10773804. DOI: 10.3389/fped.2023.1294490.

Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review.

Bai G, Tsai M, Lin S, Hsu Y, Chen S Front Microbiol. 2023; 14:1212582.

PMID: 37485533 PMC: 10359435. DOI: 10.3389/fmicb.2023.1212582.

References

Szajewska H, Kotowska M, Mrukowicz J, Armanska M, MIKOLAJCZYK W . Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001; 138(3):361-5. DOI: 10.1067/mpd.2001.111321. View

Jung K, Kim A, Lee J, Cho D, Seo J, Jung E . Effect of Oral Intake of APsulloc 331261 (GTB1) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2022; 14(10). PMC: 9144213. DOI: 10.3390/nu14102015. View

Villena J, Vizoso-Pinto M, Kitazawa H . Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection. Front Immunol. 2016; 7:563. PMC: 5136547. DOI: 10.3389/fimmu.2016.00563. View

Wahab S, Almaghaslah D, Mahmood S, Ahmad M, Alsayegh A, Abu Haddash Y . Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review. J Pers Med. 2022; 12(8). PMC: 9409792. DOI: 10.3390/jpm12081292. View

Clarke G, Stilling R, Kennedy P, Stanton C, Cryan J, Dinan T . Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28(8):1221-38. PMC: 5414803. DOI: 10.1210/me.2014-1108. View

Misra S, Sabui T, Pal N . A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea. J Pediatr. 2009; 155(1):129-32. DOI: 10.1016/j.jpeds.2009.01.060. View

Lundgren O, Svensson L . Pathogenesis of rotavirus diarrhea. Microbes Infect. 2001; 3(13):1145-56. PMC: 7128947. DOI: 10.1016/s1286-4579(01)01475-7. View

Gaon D, Garcia H, Winter L, Rodriguez N, Quintas R, Gonzalez S . Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires). 2003; 63(4):293-8. View

Belguesmia Y, Bendjeddou K, Kempf I, Boukherroub R, Drider D . Heterologous Biosynthesis of Five New Class II Bacteriocins From CNCM I-5369 With Antagonistic Activity Against Pathogenic Strains. Front Microbiol. 2020; 11:1198. PMC: 7318550. DOI: 10.3389/fmicb.2020.01198. View

10.

Zaman K, Dang D, Victor J, Shin S, Yunus M, Dallas M . Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010; 376(9741):615-23. DOI: 10.1016/S0140-6736(10)60755-6. View

11.

Pedone C, Arnaud C, Postaire E, Bouley C, Reinert P . Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract. 2001; 54(9):568-71. View

12.

Dos Reis Buzzo Zermiani A, de Paula Soares A, da Silva Guedes de Moura B, Miguel E, Lopes L, de Carvalho Scharf Santana N . Evidence of Lactobacillus reuteri to reduce colic in breastfed babies: Systematic review and meta-analysis. Complement Ther Med. 2021; 63:102781. DOI: 10.1016/j.ctim.2021.102781. View

13.

Chau T, Minh Chau N, Le N, Chung The H, Voong Vinh P, Nguyen To N . A Double-blind, Randomized, Placebo-controlled Trial of Lactobacillus acidophilus for the Treatment of Acute Watery Diarrhea in Vietnamese Children. Pediatr Infect Dis J. 2017; 37(1):35-42. PMC: 5681247. DOI: 10.1097/INF.0000000000001712. View

14.

Desselberger U . Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors. Pathogens. 2017; 6(4). PMC: 5750589. DOI: 10.3390/pathogens6040065. View

15.

Ahmadi E, Alizadeh-Navaei R, Rezai M . Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis. Caspian J Intern Med. 2015; 6(4):187-95. PMC: 4649266. View

16.

Guandalini S, Pensabene L, Zikri M, Dias J, Casali L, Hoekstra H . Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000; 30(1):54-60. DOI: 10.1097/00005176-200001000-00018. View

17.

Ettinger S . Diet, Gut Microbiome, and Cognitive Decline. Curr Nutr Rep. 2022; 11(4):643-652. DOI: 10.1007/s13668-022-00435-y. View

18.

Hojsak I, Fabiano V, Pop T, Goulet O, Zuccotti G, Cullu Cokugras F . Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Paediatr. 2018; 107(6):927-937. PMC: 5969308. DOI: 10.1111/apa.14270. View

19.

Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L . Probiotics and immune response. Am J Gastroenterol. 2000; 95(1 Suppl):S22-5. DOI: 10.1016/s0002-9270(99)00813-8. View

20.

Szymanski H, Pejcz J, Jawien M, Chmielarczyk A, Strus M, Heczko P . Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains--a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2006; 23(2):247-53. DOI: 10.1111/j.1365-2036.2006.02740.x. View